The top global KOLs in a therapy area might offer some insight into HCP behaviour in their geographies, but to understand the national and local challenges in a target region, you’ll need c
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.